Cypherpunk Technologies Ord Shs
CYPH1.570USD
+0.130+9.03%
Market hours （ET）Quotes delayed by 15 min
65.06MMarket Cap
LossP/E TTM
More Details of Company
Cypherpunk Technologies Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Cypherpunk Technologies Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Douglas E. (Doug) Onsi
Mr. Douglas E. (Doug) Onsi
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
140.87K
+30.09%
Dr. Christopher K. Mirabelli, Ph.D.
Dr. Christopher K. Mirabelli, Ph.D.
Director
Director
23.05K
--
Ms. Christine Granfield
Ms. Christine Granfield
Vice President, Head - Regulatory Affairs and Quality
Vice President, Head - Regulatory Affairs and Quality
15.90K
--
Dr. Jason Baum, Ph.D.
Dr. Jason Baum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
15.90K
--
Dr. James H. Cavanaugh, Ph.D.
Dr. James H. Cavanaugh, Ph.D.
Independent Director
Independent Director
214.00
--
Dr. William W. Li, M.D.
Dr. William W. Li, M.D.
Independent Director
Independent Director
--
--
Ms. Patricia (Patty) Martin
Ms. Patricia (Patty) Martin
Independent Director
Independent Director
--
--
Mr. William (Wil) Mcevoy
Mr. William (Wil) Mcevoy
Chief Investment Officer, Director
Chief Investment Officer, Director
--
--
Mr. Christian M. Richard
Mr. Christian M. Richard
Independent Director
Independent Director
--
--
Dr. Richard L. Schilsky, M.D.
Dr. Richard L. Schilsky, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Douglas E. (Doug) Onsi
Mr. Douglas E. (Doug) Onsi
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
140.87K
+30.09%
Dr. Christopher K. Mirabelli, Ph.D.
Dr. Christopher K. Mirabelli, Ph.D.
Director
Director
23.05K
--
Ms. Christine Granfield
Ms. Christine Granfield
Vice President, Head - Regulatory Affairs and Quality
Vice President, Head - Regulatory Affairs and Quality
15.90K
--
Dr. Jason Baum, Ph.D.
Dr. Jason Baum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
15.90K
--
Dr. James H. Cavanaugh, Ph.D.
Dr. James H. Cavanaugh, Ph.D.
Independent Director
Independent Director
214.00
--
Dr. William W. Li, M.D.
Dr. William W. Li, M.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Winklevoss Capital Management, LLC
14.62%
Severns (Sean Michael)
10.59%
Gilead Sciences Inc
9.39%
BofA Global Research (US)
2.55%
Acadian Asset Management LLC
2.18%
Other
60.66%
Shareholders
Shareholders
Proportion
Winklevoss Capital Management, LLC
14.62%
Severns (Sean Michael)
10.59%
Gilead Sciences Inc
9.39%
BofA Global Research (US)
2.55%
Acadian Asset Management LLC
2.18%
Other
60.66%
Shareholder Types
Shareholders
Proportion
Family Office
14.62%
Corporation
11.53%
Individual Investor
10.99%
Investment Advisor
6.62%
Investment Advisor/Hedge Fund
3.10%
Research Firm
2.88%
Venture Capital
1.25%
Hedge Fund
0.35%
Bank and Trust
0.01%
Other
48.66%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
105
8.04M
14.20%
-12.16M
2025Q3
110
8.07M
14.70%
-12.52M
2025Q2
113
9.14M
22.07%
-11.90M
2025Q1
128
12.05M
29.23%
-8.23M
2024Q4
125
14.62M
38.15%
-3.38M
2024Q3
131
15.40M
40.26%
-3.07M
2024Q2
132
15.45M
40.57%
-950.02K
2024Q1
142
9.18M
39.05%
-1.80M
2023Q4
148
7.57M
32.79%
-3.85M
2023Q3
162
8.45M
36.23%
-2.60M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Gilead Sciences Inc
5.32M
12.84%
--
--
Sep 30, 2025
BofA Global Research (US)
1.44M
2.55%
+1.44M
+451295.63%
Sep 30, 2025
Acadian Asset Management LLC
1.24M
2.18%
--
--
Sep 30, 2025
Beigene Ltd
1.22M
2.15%
+1.22M
--
Oct 31, 2024
The Vanguard Group, Inc.
1.16M
2.05%
--
--
Sep 30, 2025
Hightower Advisors, LLC
1.10M
1.95%
+8.00K
+0.73%
Sep 30, 2025
Simplify Asset Management Inc
975.61K
1.72%
+118.25K
+13.79%
Sep 30, 2025
HealthCare Ventures LLC
697.23K
1.68%
+20.91K
+3.09%
Apr 21, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
Simplify Health Care ETF
0.37%
DFA Dimensional US Sustainability Core 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Dimensional US Core Equity 1 ETF
0%
Simplify Health Care ETF
Proportion0.37%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Cypherpunk Technologies Ord Shs?
The top five shareholders of Cypherpunk Technologies Ord Shs are:
Gilead Sciences Inc holds 5.32M shares, accounting for 12.84% of the total shares.
BofA Global Research (US) holds 1.44M shares, accounting for 2.55% of the total shares.
Acadian Asset Management LLC holds 1.24M shares, accounting for 2.18% of the total shares.
Beigene Ltd holds 1.22M shares, accounting for 2.15% of the total shares.
The Vanguard Group, Inc. holds 1.16M shares, accounting for 2.05% of the total shares.
Gilead Sciences Inc holds 5.32M shares, accounting for 12.84% of the total shares.
BofA Global Research (US) holds 1.44M shares, accounting for 2.55% of the total shares.
Acadian Asset Management LLC holds 1.24M shares, accounting for 2.18% of the total shares.
Beigene Ltd holds 1.22M shares, accounting for 2.15% of the total shares.
The Vanguard Group, Inc. holds 1.16M shares, accounting for 2.05% of the total shares.
What are the top three shareholder types of Cypherpunk Technologies Ord Shs?
The top three shareholder types of Cypherpunk Technologies Ord Shs are:
Winklevoss Capital Management, LLC
Severns (Sean Michael)
Gilead Sciences Inc
Winklevoss Capital Management, LLC
Severns (Sean Michael)
Gilead Sciences Inc
How many institutions hold shares of Cypherpunk Technologies Ord Shs (CYPH)?
As of 2025Q4, 105 institutions hold shares of Cypherpunk Technologies Ord Shs, with a combined market value of approximately 8.04M, accounting for 14.20% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.50%.
What is the biggest source of revenue for Cypherpunk Technologies Ord Shs?
In --, the -- business generated the highest revenue for Cypherpunk Technologies Ord Shs, amounting to -- and accounting for --% of total revenue.
